

Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Lead Product(s) : Gonadorelin
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Gonadotropin is a Hormone drug candidate, which is currently being evaluated in Phase III clinical studies for the treatment of Infertility.
Product Name : Undisclosed
Product Type : Hormone
Upfront Cash : Inapplicable
October 15, 2025
Lead Product(s) : Gonadorelin
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Gonadorelin
Therapeutic Area : Oncology
Study Phase : Phase II
Sponsor : Bayer AG
Deal Size : Inapplicable
Deal Type : Inapplicable
Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response
Details : Luteinizing Hormone-Releasing Hormone is a Hormone drug candidate, which is currently being evaluated in Phase II clinical studies for the treatment of Prostatic Neoplasms, Castration-Resistant.
Product Name : Undisclosed
Product Type : Hormone
Upfront Cash : Inapplicable
August 26, 2025
Lead Product(s) : Gonadorelin
Therapeutic Area : Oncology
Highest Development Status : Phase II
Sponsor : Bayer AG
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Gonadorelin
Therapeutic Area : Oncology
Study Phase : Phase II
Sponsor : Johnson & Johnson Innovative Medicine
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Gonadotropin-Releasing Hormone is a Hormone drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Prostatic Neoplasms.
Product Name : Undisclosed
Product Type : Hormone
Upfront Cash : Inapplicable
May 05, 2017
Lead Product(s) : Gonadorelin
Therapeutic Area : Oncology
Highest Development Status : Phase II
Sponsor : Johnson & Johnson Innovative Medicine
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Gonadorelin
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : CHORAPUR (Chorionic Gonadotropin) is a Protein drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Infertility.
Product Name : CHORAPUR
Product Type : Protein
Upfront Cash : Inapplicable
May 20, 2015
Lead Product(s) : Gonadorelin
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
